Frequently Asked Questions

About the Astellas Oncology C3 Prize

What is the Astellas Oncology C3 Prize?

The C3 Prize is a challenge aimed at inspiring non-medicine and non-treatment innovation to change cancer care for patients and their loved ones. The cancer care continuum encompasses all phases of care during illness, from diagnosis to the end of life.1

Three prizes will be awarded as follows: one $50,000 grant and two $25,000 grants. These grants are meant to help winners further develop their ideas and bring them to life. Additionally, Astellas may also, at its sole discretion, assist winners in developing their idea. The three grant winners will also receive a one year membership to MATTER, the Chicago-based healthcare technology incubator and community hub.

The Astellas Oncology C3 Prize is subject to all applicable federal, state, provincial and local laws and regulations. Astellas Pharma reserves the right to change, alter, or modify these rules and/or dates at any time without notice.

What sort of ideas is the Astellas Oncology C3 Prize looking for?

The Astellas Oncology C3 Prize is looking for an idea to develop a new innovation that addresses a major issue in cancer care including but not limited to, at least one of the following areas:

  • Navigation – Innovative tools, methods or processes are needed to help guide patients living with cancer and their loved ones through the healthcare system and to reduce the burden of decision making, so that patients are able to better focus on their personal health.
  • Adherence – Innovative tools, methods or processes are needed to help patients living with cancer be more successful in adhering to a treatment plan and to help increase medication compliance.
  • Care Coordination – Innovative tools, methods or processes are needed to provide clarity and ease to patients living with cancer and caregivers around improving how care is networked, coordinated and delivered.
  • Survivorship – Innovative tools, methods or processes are needed to develop support systems for patients, caregivers and others impacted by cancer as more people live longer with the disease or live longer cancer-free.

Entrants should let us know what they think the biggest problem is, their idea/solution to tackle that problem and the potential impact of that idea/solution in the cancer community.

Application Requirements and Deadlines

When does the Astellas Oncology C3 Prize contest begin and when will the winners be announced?

The timing for the Astellas Oncology C3 Prize is as follows:

  • The Challenge will launch on April 25, 2016 during the WMIF Annual Meeting in Boston.
  • Five finalists will be selected and notified on or about August 15, 2016 and invited to pitch their ideas, at no cost, in front of a live panel of judges at the Stanford Medicine X conference on September 17, 2016 in Stanford, CA. Among the judges will be technology entrepreneur, passionate cancer patient caregiver, and one of the stars of ABC’s Emmy Award-winning hit television show Shark Tank, Robert Herjavec.
  • The grand prize winner of the C3 Prize will be invited to and announced in October at the 2016 ESMO Congress in Copenhagen, Denmark.

Who is eligible to apply?

To be eligible to enter the Challenge, you must: (1) be above the age of majority in the country, state, province, or jurisdiction of residence (and at least twenty (20) years old in Taiwan) at the time of entry; (2) not be a resident of Brazil, Crimea, Cuba, Iran, Syria, North Korea, Sudan and where prohibited by law; (3) not be a person or entity under U.S. export controls or sanctions; and (4) have access to the Internet as of April 25, 2016.

Please see our Terms & Conditions for all eligibility information.

Individuals and/or groups may apply. It is not necessary for Entrants to have taken, currently take, or intend to take in the future, any medicine or product marketed by Astellas, and this will not be a consideration in the selection criteria.

It is not necessary for Healthcare Provider Entrants to prescribe, or intend to prescribe in the future, any medicine or product marketed by Astellas, and this will not be a consideration in the selection criteria.

Submission guidelines are included in the application. By participating, Entrants agree to these terms and conditions and the decisions of the judges and/or sponsors, which are binding and final on matters relating to this challenge.

Who is not eligible to apply?

Employees, interns, contractors and official office-holders of Astellas Pharma Inc., its subsidiaries, affiliates and their respective directors, officers, employees, advertising and promotion agencies, representatives and agents, and their immediate families (parents, siblings, children, spouses and life partners of each, regardless of where they live) and members of the households (whether related or not) of such employees, officers and directors are ineligible to participate in this Challenge. Please see our Terms & Conditions for all eligibility information.

How do I apply for the Challenge?

Entrants can apply online at www.C3Prize.com between 12:00:00 A.M. Central Time (CT) zone in the United States on April 25, 2016 through 11:59:59 P.M. CT on August 8, 2016. All application requirements can be found at www.C3Prize.com.

How many times can I apply?

Only one application per individual or group will be accepted.

Winner Selection and Prize Rules

How many winners will be selected? How will we know who has won?

One grand prize winner and two additional winners will be selected. The Astellas Oncology C3 Prize milestones are as follows:

  • The Challenge will launch on April 25, 2016 during the WMIF Annual Meeting in Boston.
  • Five finalists will be invited to pitch their ideas in front of a live panel of judges at the Stanford Medicine X conference on September 17, 2016.
  • The grand prize winner of the Astellas Oncology C3 Prize will be announced at the ESMO Congress in Copenhagen, Denmark in October. There will also be two other winners that will be announced, but they may not necessarily be invited to attend the ESMO Congress.

What will the winner(s) of the Astellas Oncology C3 Prize receive?

Three prizes will be awarded as follows: one $50,000 grant and two $25,000 grants. These grants are meant to help winners further develop their ideas and bring them to life. Additionally, Astellas may also, at its sole discretion, assist winners in developing their idea. The three grant winners will also receive a one year membership to MATTER, the Chicago-based healthcare technology incubator and community hub.

How can the 2016 Astellas Oncology C3 Prize grant money be used?

The Astellas Oncology C3 Prize grant can be used to bring the winners’ ideas to life. The Challenge winners will develop a project plan detailing how they intend to use their grant and representatives of the C3 Prize may support this work along the way.

What is the MATTER membership?

MATTER is built for entrepreneurs and innovators in the fields of medical device, healthcare IT, medical diagnostics and biopharmaceuticals who are looking for flexible, affordable co-working space, mentoring and resources with which to grow their companies.  MATTER’s one year membership will vary based on location of winners, but will include perks such as access to MATTER, use of community workspaces and access to the MATTER mentor network. For more information, visit www.matterchicago.com.

Who chooses the finalists and winners?

Online forms and videos will be judged by a panel of experts.

How will the finalists and winners be selected?

Online forms and videos will be evaluated by the judges based on the following criteria: plausibility of idea (35%), creativity and originality of innovation (35%), and the ability of Entrant to operationalize/implement the innovative idea for future application (30%). All decisions made by the judging panel are final. See the Terms & Conditions for more information on judging criteria.

If I have questions that aren’t addressed here, where can I get more information?

If you have additional questions, please contact the program administrator at C3Prize@astellas.com.

Read the Terms & Conditions